279 related articles for article (PubMed ID: 25323828)
1. Current treatments in familial dysautonomia.
Palma JA; Norcliffe-Kaufmann L; Fuente-Mora C; Percival L; Mendoza-Santiesteban C; Kaufmann H
Expert Opin Pharmacother; 2014 Dec; 15(18):2653-71. PubMed ID: 25323828
[TBL] [Abstract][Full Text] [Related]
2. Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
Yoshida M; Kataoka N; Miyauchi K; Ohe K; Iida K; Yoshida S; Nojima T; Okuno Y; Onogi H; Usui T; Takeuchi A; Hosoya T; Suzuki T; Hagiwara M
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2764-9. PubMed ID: 25675486
[TBL] [Abstract][Full Text] [Related]
3. [Molecular and cellular characterization ion of IKAP protein and the Elongator complex. Implications for familial dysautonomia].
Close P; Creppe C; Cornez I; Chariot A
Bull Mem Acad R Med Belg; 2007; 162(5-6):315-22. PubMed ID: 18405001
[TBL] [Abstract][Full Text] [Related]
4. ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.
Morini E; Gao D; Montgomery CM; Salani M; Mazzasette C; Krussig TA; Swain B; Dietrich P; Narasimhan J; Gabbeta V; Dakka A; Hedrick J; Zhao X; Weetall M; Naryshkin NA; Wojtkiewicz GG; Ko CP; Talkowski ME; Dragatsis I; Slaugenhaupt SA
Am J Hum Genet; 2019 Apr; 104(4):638-650. PubMed ID: 30905397
[TBL] [Abstract][Full Text] [Related]
5. Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.
Morini E; Dietrich P; Salani M; Downs HM; Wojtkiewicz GR; Alli S; Brenner A; Nilbratt M; LeClair JW; Oaklander AL; Slaugenhaupt SA; Dragatsis I
Hum Mol Genet; 2016 Mar; 25(6):1116-28. PubMed ID: 26769677
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial treatment increases IKAP levels in human cells generated from Familial Dysautonomia patients.
Yannai S; Zonszain J; Donyo M; Ast G
PLoS One; 2019; 14(3):e0211602. PubMed ID: 30889183
[TBL] [Abstract][Full Text] [Related]
7. Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.
Gold-von Simson G; Goldberg JD; Rolnitzky LM; Mull J; Leyne M; Voustianiouk A; Slaugenhaupt SA; Axelrod FB
Pediatr Res; 2009 Mar; 65(3):341-6. PubMed ID: 19033881
[TBL] [Abstract][Full Text] [Related]
8. BGP-15 prevents the death of neurons in a mouse model of familial dysautonomia.
Ohlen SB; Russell ML; Brownstein MJ; Lefcort F
Proc Natl Acad Sci U S A; 2017 May; 114(19):5035-5040. PubMed ID: 28439028
[TBL] [Abstract][Full Text] [Related]
9. Familial dysautonomia: a review of the current pharmacological treatments.
Axelrod FB
Expert Opin Pharmacother; 2005 Apr; 6(4):561-7. PubMed ID: 15934882
[TBL] [Abstract][Full Text] [Related]
10. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.
Axelrod FB; Liebes L; Gold-Von Simson G; Mendoza S; Mull J; Leyne M; Norcliffe-Kaufmann L; Kaufmann H; Slaugenhaupt SA
Pediatr Res; 2011 Nov; 70(5):480-3. PubMed ID: 21775922
[TBL] [Abstract][Full Text] [Related]
11. Of splice and men: what does the distribution of IKAP mRNA in the rat tell us about the pathogenesis of familial dysautonomia?
Mezey E; Parmalee A; Szalayova I; Gill SP; Cuajungco MP; Leyne M; Slaugenhaupt SA; Brownstein MJ
Brain Res; 2003 Sep; 983(1-2):209-14. PubMed ID: 12914982
[TBL] [Abstract][Full Text] [Related]
12. The familial dysautonomia disease gene
Chaverra M; George L; Mergy M; Waller H; Kujawa K; Murnion C; Sharples E; Thorne J; Podgajny N; Grindeland A; Ueki Y; Eiger S; Cusick C; Babcock AM; Carlson GA; Lefcort F
Dis Model Mech; 2017 May; 10(5):605-618. PubMed ID: 28167615
[TBL] [Abstract][Full Text] [Related]
13. Afferent baroreflex failure in familial dysautonomia.
Norcliffe-Kaufmann L; Axelrod F; Kaufmann H
Neurology; 2010 Nov; 75(21):1904-11. PubMed ID: 21098405
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells.
Keren H; Donyo M; Zeevi D; Maayan C; Pupko T; Ast G
PLoS One; 2010 Dec; 5(12):e15884. PubMed ID: 21209961
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia.
Hervé M; Ibrahim EC
Neurobiol Dis; 2017 Jul; 103():113-122. PubMed ID: 28404519
[TBL] [Abstract][Full Text] [Related]
16. Familial dysautonomia.
Slaugenhaupt SA; Gusella JF
Curr Opin Genet Dev; 2002 Jun; 12(3):307-11. PubMed ID: 12076674
[TBL] [Abstract][Full Text] [Related]
17. Retina-specific loss of
Ueki Y; Shchepetkina V; Lefcort F
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29929962
[TBL] [Abstract][Full Text] [Related]
18. Familial dysautonomia.
Axelrod FB
Muscle Nerve; 2004 Mar; 29(3):352-63. PubMed ID: 14981733
[TBL] [Abstract][Full Text] [Related]
19. Effects of IKAP/hELP1 deficiency on gene expression in differentiating neuroblastoma cells: implications for familial dysautonomia.
Cohen-Kupiec R; Pasmanik-Chor M; Oron-Karni V; Weil M
PLoS One; 2011 Apr; 6(4):e19147. PubMed ID: 21559466
[TBL] [Abstract][Full Text] [Related]
20. Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.
Cheishvili D; Maayan C; Holzer N; Tsenter J; Lax E; Petropoulos S; Razin A
J Mol Neurosci; 2016 Jul; 59(3):382-91. PubMed ID: 27129499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
